Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.

Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K.

J Clin Endocrinol Metab. 2007 Jun;92(6):2197-200. Epub 2007 Mar 13.

PMID:
17356042
2.

Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.

Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H.

J Clin Endocrinol Metab. 2006 Oct;91(10):3885-90. Epub 2006 Aug 1.

PMID:
16882752
3.

Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.

Goldrat O, Gervy C, Englert Y, Delbaere A, Demeestere I.

Hum Reprod. 2015 Sep;30(9):2184-9. doi: 10.1093/humrep/dev155. Epub 2015 Jun 24.

PMID:
26109617
7.

Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.

Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z.

J Clin Oncol. 2005 Jul 1;23(19):4347-53. Epub 2005 Apr 11.

PMID:
15824416
8.

Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?

Revelli A, Porcu E, Levi Setti PE, Delle Piane L, Merlo DF, Anserini P.

Gynecol Endocrinol. 2013 Nov;29(11):993-6. doi: 10.3109/09513590.2013.819083. Epub 2013 Sep 3.

PMID:
24000936
10.

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.

Turan V, Bedoschi G, Moy F, Oktay K.

Fertil Steril. 2013 Dec;100(6):1681-5.e1. doi: 10.1016/j.fertnstert.2013.08.030. Epub 2013 Sep 19.

11.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, Kuchuk I, Hourvitz A, Levron J, Mozer-Mendel M, Brengauz M, Biderman H, Manela D, Catane R, Dor J, Orvieto R, Kaufman B.

Fertil Steril. 2014 Aug;102(2):488-495.e3. doi: 10.1016/j.fertnstert.2014.05.017. Epub 2014 Jun 14.

PMID:
24934489
12.

Response to ovarian stimulation in patients facing gonadotoxic therapy.

Johnson LN, Dillon KE, Sammel MD, Efymow BL, Mainigi MA, Dokras A, Gracia CR.

Reprod Biomed Online. 2013 Apr;26(4):337-44. doi: 10.1016/j.rbmo.2013.01.003. Epub 2013 Jan 19.

13.

Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.

Azim AA, Costantini-Ferrando M, Oktay K.

J Clin Oncol. 2008 Jun 1;26(16):2630-5. doi: 10.1200/JCO.2007.14.8700.

PMID:
18509175
14.

The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.

Rodgers RJ, Reid GD, Koch J, Deans R, Ledger WL, Friedlander M, Gilchrist RB, Walters KA, Abbott JA.

Hum Reprod. 2017 May 1;32(5):1033-1045. doi: 10.1093/humrep/dex027.

PMID:
28333356
15.

In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.

Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL.

Fertil Steril. 2008 Jan;89(1):228.e19-22. Epub 2007 May 22.

PMID:
17517403
16.
17.
18.

[Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].

Chen ZJ, Shi YH, Li Y, Gao Q, Sheng Y, Ma ZX.

Zhonghua Fu Chan Ke Za Zhi. 2008 Aug;43(8):571-5. Chinese.

PMID:
19087489
19.

Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.

Lossl K, Andersen CY, Loft A, Freiesleben NL, Bangsbøll S, Andersen AN.

Hum Reprod. 2008 Aug;23(8):1820-9. doi: 10.1093/humrep/den131. Epub 2008 May 15.

PMID:
18487212

Supplemental Content

Support Center